Hepatology

Hepatology Review CME / CPD 

Full Course:  20 AMA PRA Category 1 Credits for CME / CEU / CPD

Short Course:  10 AMA PRA Category 1 Credits for CME / CEU / CPD

Course(s) are appropriate for:   Family Practitioners, Pediatricians, Internists, General Practitioners, Nurses, Nurse Practitioners, Physician Assistants (PA-C's)

Series 3 (HP3) Topics Include:  Pediatric Candidates, NAFLD, NASH, Pharmacologic Interventions, Liver Hypertrophy, and more.

To view topic outline of the full or short course, select the Course Type (Full or Short) below:

Full Course:
HP3
Full Course Price:
$580
Short Course:
HP3A, HP3B
Short Course Price:
$485
Format:
Available in Audio format.

Course Topics

Update on Liver Transplantation

Select pediatric candidates for liver transplantation based on appropriateness of the indication and predicted improvement in survival and outcome; Summarize the factors that determine priority for organ allocation in pediatric patients; Develop strategies for optimizing medical management and surgical techniques to improve outcomes in

Hepatocellular Carcinoma

Analyze current and future epidemiologic trends in risk factors for HCC in the United States; Maximize the effectiveness of surveillance for HCC in clinical practice; Optimize the use of diagnostic evaluation and treatment modalities for patients with HCC; Recognize factors that increase risk for acute cellular rejection or treatment failure following LT; . Identify patients with HCC who are likely to benefit from LT with or without prior downstaging.

Chronic Liver Disease

Evaluate the benefits and limitations of liver biopsies, transient elastography, and serum markers for assessment of liver fibrosis and cirrhosis; Apply protocols for noninvasive assessment of liver fibrosis and cirrhosis in patients with viral hepatitis, nonalcoholic fatty liver disease, or autoimmune hepatitis; Summarize dietary and lifestyle factors associated with recent trends in obesity in the United States; Explain how drugs and different types of carbohydrates influence fatty acid synthesis and export in the liver; Prescribe lifestyle interventions to improve metabolic health in patients at high risk for fatty liver disease.

Liver Problems

Manage cerebral edema, coagulopathy, and renal failure associated with acute liver failure; Summarize diagnostic criteria for acute kidney injury in patients with chronic liver disease; Treat hepatorenal syndrome using pharmacologic or surgical therapies; Identify risk factors for rapid progression of hepatic varices to variceal hemorrhage; Use pharmacologic and endoscopic interventions to manage hepatic varices and variceal hemorrhage.

NASH and Acute Liver Failure

Identify clinical and histologic risk factors for NASH; Discuss the benefits and drawbacks of liver biopsy for identification of NASH in patients with nonalcoholic fatty liver disease (NAFLD); Estimate the accuracy of noninvasive methods for predicting liver fibrosis in patients with NAFLD; Summarize potential targets for pharmaceutical treatment of NASH; Manage patients with hepatic obstruction based on degree of veno-occlusion and severity of liver disease.

H021

Hepatitis B/Hepatitis C

Elaborate on the replication and life cycle of HBV and how these are used as potential targets for therapy; Perform screening tests to identify individuals who can benefit from HBV immunization, individuals exposed to HBV, and individuals with chronic HBV infection; Identify barriers to curing HBV infection; Use appropriate scoring systems and tests to stage chronic HCV infection; Minimize drug-drug interactions between direct-acting antivirals.

Liver Transplantation 2017

Analyze recent data on the association between obesity and outcomes of hepatic resection and liver transplantation; Apply standardized approaches for weight loss in the treatment of obese candidates for liver transplantation; Explain the allocation of donor organs based on assessment of need and predicted survival rate after transplantation; Recognize the benefits and drawbacks of recent policy changes for improving access to liver transplantation; Assess potential sources of donors in liver transplantation to reduce the gap between supply and demand.

H020

Complications of Liver Disease

List causes of poor surgical outcomes in patients with liver disease; Evaluate risk for perioperative morbidity and mortality according to severity of cirrhosis and type of surgical procedure; Provide appropriate screening and diagnostic tests for patients at high risk for HCC; Treat HCC based on size and number of lesions, liver function, and eligibility for surgery; Consider procedures for inducing liver hypertrophy or downstaging HCC prior to resection or transplantation.

Diabetes and Liver Disease

Discuss potential ways of overcoming limitations in diagnosis, assessment of disease progression, and management of NAFLD and NASH; Identify environmental and genetic factors associated with rapid disease progression; Summarize targets for drugs that reduce the progression of NASH or liver fibrosis; Individualize treatment for patients with metabolic syndrome based on which organs show abnormal function.

Complications of Liver Transplantation

Select patients with HCC who are most likely to benefit from liver transplantation; Identify methods to increase the donor pool for liver transplantation; Compare ex vivo methods for preserving the function of donor livers; Use a scoring system to predict outcomes of patients in the ICU; Choose among liver-specific scoring systems to determine risk for death among patients with cirrhosis staying in the ICU.

Update on Liver Transplantation

Select pediatric candidates for liver transplantation based on appropriateness of the indication and predicted improvement in survival and outcome; Summarize the factors that determine priority for organ allocation in pediatric patients; Develop strategies for optimizing medical management and surgical techniques to improve outcomes in

Chronic Liver Disease

Evaluate the benefits and limitations of liver biopsies, transient elastography, and serum markers for assessment of liver fibrosis and cirrhosis; Apply protocols for noninvasive assessment of liver fibrosis and cirrhosis in patients with viral hepatitis, nonalcoholic fatty liver disease, or autoimmune hepatitis; Summarize dietary and lifestyle factors associated with recent trends in obesity in the United States; Explain how drugs and different types of carbohydrates influence fatty acid synthesis and export in the liver; Prescribe lifestyle interventions to improve metabolic health in patients at high risk for fatty liver disease.

NASH and Acute Liver Failure

Identify clinical and histologic risk factors for NASH; Discuss the benefits and drawbacks of liver biopsy for identification of NASH in patients with nonalcoholic fatty liver disease (NAFLD); Estimate the accuracy of noninvasive methods for predicting liver fibrosis in patients with NAFLD; Summarize potential targets for pharmaceutical treatment of NASH; Manage patients with hepatic obstruction based on degree of veno-occlusion and severity of liver disease.

H021

Liver Transplantation 2017

Analyze recent data on the association between obesity and outcomes of hepatic resection and liver transplantation; Apply standardized approaches for weight loss in the treatment of obese candidates for liver transplantation; Explain the allocation of donor organs based on assessment of need and predicted survival rate after transplantation; Recognize the benefits and drawbacks of recent policy changes for improving access to liver transplantation; Assess potential sources of donors in liver transplantation to reduce the gap between supply and demand.

H020

Diabetes and Liver Disease

Discuss potential ways of overcoming limitations in diagnosis, assessment of disease progression, and management of NAFLD and NASH; Identify environmental and genetic factors associated with rapid disease progression; Summarize targets for drugs that reduce the progression of NASH or liver fibrosis; Individualize treatment for patients with metabolic syndrome based on which organs show abnormal function.

Hepatocellular Carcinoma

Analyze current and future epidemiologic trends in risk factors for HCC in the United States; Maximize the effectiveness of surveillance for HCC in clinical practice; Optimize the use of diagnostic evaluation and treatment modalities for patients with HCC; Recognize factors that increase risk for acute cellular rejection or treatment failure following LT; . Identify patients with HCC who are likely to benefit from LT with or without prior downstaging.

Liver Problems

Manage cerebral edema, coagulopathy, and renal failure associated with acute liver failure; Summarize diagnostic criteria for acute kidney injury in patients with chronic liver disease; Treat hepatorenal syndrome using pharmacologic or surgical therapies; Identify risk factors for rapid progression of hepatic varices to variceal hemorrhage; Use pharmacologic and endoscopic interventions to manage hepatic varices and variceal hemorrhage.

Hepatitis B/Hepatitis C

Elaborate on the replication and life cycle of HBV and how these are used as potential targets for therapy; Perform screening tests to identify individuals who can benefit from HBV immunization, individuals exposed to HBV, and individuals with chronic HBV infection; Identify barriers to curing HBV infection; Use appropriate scoring systems and tests to stage chronic HCV infection; Minimize drug-drug interactions between direct-acting antivirals.

Complications of Liver Disease

List causes of poor surgical outcomes in patients with liver disease; Evaluate risk for perioperative morbidity and mortality according to severity of cirrhosis and type of surgical procedure; Provide appropriate screening and diagnostic tests for patients at high risk for HCC; Treat HCC based on size and number of lesions, liver function, and eligibility for surgery; Consider procedures for inducing liver hypertrophy or downstaging HCC prior to resection or transplantation.

Complications of Liver Transplantation

Select patients with HCC who are most likely to benefit from liver transplantation; Identify methods to increase the donor pool for liver transplantation; Compare ex vivo methods for preserving the function of donor livers; Use a scoring system to predict outcomes of patients in the ICU; Choose among liver-specific scoring systems to determine risk for death among patients with cirrhosis staying in the ICU.

Additional Information

Additional Continuing Medical Education options available:

Other courses of interest may include:  PediatricsFamily PracticeInternal Medicine and Nutrition.

If you have taken the current Hepatology CME / CPD Review listed above or if you are seeking additional credits, please visit: Medical Courses Coming Soon There you will find abbreviated listings of additional courses available related to this specialty and courses that are soon to be released.

For over 30 years, ASI has provided Continuing Medical Education, CME & CEU and Continuing Professional Development Education (CPD) for physicians and allied professionals in Hepatology plus over 40 other specialties and subspecialties.  Lectures are recorded annually at the top seminars and conferences to provide the most current medical education to our clients.